Market access
We bring our experience in cross-functional coordination, anticipation of payer evaluation criteria during the clinical development and registration process to define an access strategy and contingency plans.
#Early access, #Comparators, #Transparency, #Medical economics, #Evaluation, #Reimbursement, #Pricing, #Health economics
Bernard Hamelin
More than 25 years of experience in France and abroad in the fields of clinical development and medical affairs.
Robert Dahan
Double medical and commercial expertise to serve innovation and to optimize use of medicines.
